Scientists led by Javier Martinez from the Max Perutz Labs, a joint venture of the Medical University of Vienna and the University of Vienna, have identified a unique chemical reaction at the end of RNA molecules for the first time in human cells. This reaction was previously only observed in bacteria and viruses. Tracing its source among thousands of proteins, they discovered that an unexpected culprit, an enzyme called ANGEL2, executes this reaction. ANGEL2 may play a key role in regulating the response to cellular stress, and possibly in the pathogenesis of neurodegenerative and metabolic diseases. The study is published in “Science”.
Advances in neuroscience research and microscopy: a collaborative project driven by researchers of the Max Perutz Labs Vienna, a joint venture of the University of Vienna and the Medical University of Vienna, and the TU Wien (Vienna) allows researchers to look deep into organs and nervous systems of animals, ranging from squids and worms to fish and salamanders.
The Vienna Covid-19 Diagnostics Initiative (VCDI) is a collaborative effort involving 20 scientific institutions across Vienna. The initiative has repurposed existing infrastructure, resources, and manpower to build a new diagnostics pipeline for the SARS-CoV-2 coronavirus. The initiative freely disseminates its know-how, operating procedures and latest developments. The VCDI is funded by the COVID-19 Rapid Response Call of the Vienna Science and Technology Fund (WWTF).
A marvel of complexity, the nucleus is the command center of the cell – harboring information, codes and controlled access. But different from man-made command centers, the nuclear interior looks chaotic to the eye of a scientist. Chromosomes, the carriers of genetic information, float amidst a sea of water, proteins, nucleic acids and other molecules, all engaged in a myriad of simultaneous reactions. These reactions have one major goal: to turn genes on and off at the right time and place. This process is called gene regulation and makes a brain cell look and act different from a muscle cell or a liver cell.
Infections by human fungal pathogens cause about 1.5 million deaths each year – interfering with iron utilization in the fungus promises new therapeutic approaches.